Check out the recap from John Roy, Ph.D.'s latest podcast with Oren Hershkovitz, CEO of Enlivex Ltd. (NASDAQ: $ENLV). Those interested can listen to the podcast on all platforms or on our website. Links are accessible in our full report! $ENLV #Enlivex# #Biotech# #Immunotherapy# #DigitalAssets# #Crypto# #Blockchain# #PredictionMarkets# #HealthcareInnovation# #ClinicalTrials# #DrugDevelopment# #Web3# #Tokenization# #SmallCapStocks# #InvestorInsights# #WaterTowerResearch# @Enlivex

A new push to loosen federal restrictions on peptides could fuel a boom similar to weight-loss drugs — even as research and clinical trials lag. Go deeper:

A study published in the BMJ tested whether non-invasive brain stimulation could improve social communication in autistic children with intellectual disabilities — a group often excluded from clinical trials. Researchers from Cambridge, Shanghai Jiao Tong University, and Fudan University administered theta-burst stimulation, a technique that delivers rapid magnetic pulses through the skull to stimulate specific neurons, over just five days. Each session lasted only a few minutes. Compared to a sham control group, children who received real stimulation showed significant improvements in social communication and language ability — gains that were still measurable a month later. No serious side effects were reported. Around 30-35% of autistic children have an intellectual disability, yet they are consistently underserved by existing therapies. The researchers stress the technique is not a replacement for behavioral support, but a five-day course represents a fundamentally different proposition for families already stretched thin. #Autism# #Neuroscience# #BrainStimulation# #MedicalResearch# #ChildHealth#

What if healthcare’s biggest challenge isn’t technology… but coordination? At the USC VanEck Southern California Blockchain Conference, our Co-founder & CEO, Dr Tuan Cao, shared his perspective that healthcare and pharma are fundamentally coordination problems. Clinical trials, sponsors, hospitals, auditors, experts, and patient participants all require coordination.

Great products are built by great teams. Category-defining ones are built by people like our new Chief Scientist. Meet our Chief Scientist: Fei. Fei joins Donut from the frontier of AI, working at the intersection of intelligence and real-world systems. From Tsinghua, Caltech, to Fei has helped shape how AI interfaces with societal needs across clinical trials, political systems, and education, not just in theory, but through systems that actually operate in the real world. At Donut, that thinking sharpens into something bigger. If machines can think, they can act with self-hosted infra, and if they can act, they can move money in every market when prioritizing constraints. That’s the direction we’re building with D0. Also, Fei loves 'games' like IOI (International Olympiad in Informatics), which has accidentally become a good label for modern AI.